Spontaneous rupture of kidney during pregnancy
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:34 |
|---|---|
| Enthalten in: |
Journal of biological regulators and homeostatic agents - 34(2020), 2 vom: 21. März, Seite 643-646 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Meng, H [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Angiomyolipoma rupture |
|---|
| Anmerkungen: |
Date Completed 03.11.2020 Date Revised 03.11.2020 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.23812/20-84-L-34 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM310424119 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM310424119 | ||
| 003 | DE-627 | ||
| 005 | 20231225140046.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.23812/20-84-L-34 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1034.xml |
| 035 | |a (DE-627)NLM310424119 | ||
| 035 | |a (NLM)32460466 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Meng, H |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Spontaneous rupture of kidney during pregnancy |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 03.11.2020 | ||
| 500 | |a Date Revised 03.11.2020 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a angiomyolipoma rupture | |
| 650 | 4 | |a pregnancy | |
| 650 | 4 | |a renal angiomyolipoma | |
| 650 | 4 | |a renal artery embolization | |
| 650 | 4 | |a spontaneous rupture | |
| 700 | 1 | |a Mo, Y |e verfasserin |4 aut | |
| 700 | 1 | |a Cheng, T |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, H |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, L |e verfasserin |4 aut | |
| 700 | 1 | |a Shah, N K |e verfasserin |4 aut | |
| 700 | 1 | |a Shu, C |e verfasserin |4 aut | |
| 700 | 1 | |a He, J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of biological regulators and homeostatic agents |d 1989 |g 34(2020), 2 vom: 21. März, Seite 643-646 |w (DE-627)NLM012600660 |x 0393-974X |7 nnns |
| 773 | 1 | 8 | |g volume:34 |g year:2020 |g number:2 |g day:21 |g month:03 |g pages:643-646 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.23812/20-84-L-34 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 34 |j 2020 |e 2 |b 21 |c 03 |h 643-646 | ||